Balanced news tone
News Sentiment
MED sentiment intelligence
MEDIFAST INC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
85/100 classification confidence.
directly relevant articles
high-authority source matches
-2.2% over one week, -9.8% over four weeks, trend inactive, and below fair value.
Medifast (NYSE:MED) Upgraded by Zacks Research to Strong-Buy Rating
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Medifast (NYSE:MED) Upgraded by Zacks Research to Strong-Buy Rating
Zacks Research has upgraded Medifast (NYSE:MED) from a "hold" to a "strong-buy" rating. Despite this, the broader analyst consensus for Medifast remains a "Hold" with an average target price of $12.00, and the stock recently traded below its 50-day and 200-day moving averages. Th
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 15 Jul 2026 10:41
- Source
- MarketBeat
A Look Back at Personal Care Stocks’ Q1 Earnings: Medifast (NYSE:MED) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 17:59
- Source
- Market source
Medifast Inc (NYSE: MED) director details indirect fund-held share ownership in Form 3/A
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 10:47
- Source
- Stock Titan
Medifast Inc extends its weight-loss pivot as investors watch for the next strategic move
Medifast Inc is adapting its weight-loss business to changing market demands by focusing on structured programs that combine nutrition, coaching, and digital tools. The company is refining its sales model by emphasizing direct sales and independent coaching networks, while mainta
- Tone
- Positive 61/100
- Event
- Market update
- Published
- 08 Jul 2026 19:50
- Source
- Ad-hoc-news.de
Medifast Essential 4&2&1 Plan Kit from Medifast Inc. - structured weight-loss bundle for US dieters
Medifast Inc. offers the Essential 4&2&1 Plan Kit, a structured weight-loss program for US consumers featuring portion-controlled meals. This kit supports the 4&2&1 plan, combining four meal replacements, two lean-and-green meals, and one snack daily, costing around $400–$450 mon
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 08 Jul 2026 03:41
- Source
- AD HOC NEWS
Enterprise value to EBIT forward of MEDIFAST INC – NYSE:MED
The article focuses on the "Enterprise value to EBIT forward" metric for MEDIFAST INC (NYSE: MED). It presents this financial data point within the context of TradingView's platform, indicating that the information is related to the company's financial performance.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 11:10
- Source
- TradingView
Medifast (MED) Short Interest & Short Float | Updated Jul 2026
Medifast (MED) currently has a short interest of 2.16 million shares, representing 20.13% of its public float, as of June 15, 2026. This marks a slight decrease of 0.91% from the previous reporting period. The short interest ratio is 15.3 days to cover, indicating significant pes
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 17:12
- Source
- MarketBeat
Medifast Inc focus on weight-loss programs as industry shifts
Medifast Inc is adapting its weight-loss and nutrition programs in response to changing consumer demands and the rise of pharmacological treatments for obesity. The company emphasizes structured meal plans, coaching, and long-term behavior change, balancing simplicity with flexib
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 15:39
- Source
- Ad-hoc-news.de
Medifast, Inc.(NYSE: MED) dropped from Russell 3000E Index
Medifast, Inc. (NYSE: MED) has been dropped from the Russell 3000E Index, following its earlier removal from several other Russell indices on June 29. The company also announced the resignation of Jason L. Groves as Chief Legal Officer and Corporate Secretary, effective May 29, 2
- Tone
- Negative 29/100
- Event
- Market update
- Published
- 30 Jun 2026 19:41
- Source
- www.marketscreener.com
Medifast, Inc.(NYSE: MED) dropped from Russell 2000 Value Benchmark
Medifast, Inc. (NYSE: MED) has been removed from the Russell 2000 Value Benchmark. The company, a health and wellness firm known for its OPTAVIA brand, announced this development on June 29, 2026, and also recently appointed Nicholas Johnson as its new CEO. The article includes r
- Tone
- Negative 35/100
- Event
- Market update
- Published
- 29 Jun 2026 12:11
- Source
- marketscreener.com
Price to sales forward of MEDIFAST INC – NYSE:MED
This article provides a brief overview of the "Price to sales forward" metric for MEDIFAST INC (NYSE: MED) on TradingView. It indicates that the market is closed with no trades and lists the company's financial information, news, and other data available on the platform. The cont
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 13:40
- Source
- TradingView
Price to earnings forward of Medifast, Inc. – BMV:MED
This article provides financial information for Medifast, Inc. (BMV:MED) specifically focusing on its forward price-to-earnings ratio. It presents a table with details on the period, value, and change for this financial metric, indicating that the data is made by humans. The cont
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Jun 2026 09:39
- Source
- TradingView
OPTAVIA Essential 1 Bar from Medifast Inc. - portion-controlled fuel for busy investors
The article highlights the OPTAVIA Essential 1 Bar from Medifast Inc. as a portion-controlled meal replacement integral to the OPTAVIA weight management program. It details the bar's design for fixed "Fueling" units, its role in a coach-supported system, and its impact on Medifas
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 28 Jun 2026 03:39
- Source
- Ad-hoc-news.de
Enterprise value to EBIT forward of Medifast, Inc. – BMV:MED
This article focuses on the enterprise value to EBIT forward of Medifast, Inc. (BMV:MED). It is a financial snapshot provided by TradingView, detailing a specific financial metric for the company's stock performance. The content includes market data and references from FactSet an
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 19:11
- Source
- TradingView
Medifast, Inc. Actuals & Estimates (BMV:MED)
This article provides an overview of Medifast, Inc. (BMV:MED) stock, including its current price, market capitalization, and historical performance. It also details financial estimates, actual earnings, revenue data, and employee numbers, alongside analyst opinions and future for
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jun 2026 10:40
- Source
- TradingView
Enterprise value to EBITDA forward of MEDIFAST INC – NYSE:MED
This article displays the "Enterprise value to EBITDA forward" for MEDIFAST INC, traded on the NYSE under the symbol MED. It shows the period, value, change, and percentage change. The data is provided by FactSet Research Systems Inc.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 07:40
- Source
- TradingView
Medifast, Inc. Actuals & Estimates (BOATS:MED)
This article provides an overview of Medifast, Inc. (BOATS:MED) stock, including financial actuals and analyst estimates. It covers details such as earnings, revenue, net income, EBITDA, employee count, historical stock prices, and future earnings report dates. The content aims t
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jun 2026 07:40
- Source
- TradingView
Price to book forward of Medifast, Inc. – BIVA:MED
This article provides key financial information for Medifast, Inc. (BIVA:MED), specifically focusing on its price to book forward ratio. It highlights that the market is currently closed with no trades, and offers a brief overview of the company's financials, news, community, and
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 18:39
- Source
- TradingView
Medifast, Inc. Actuals & Estimates (NYSE:MED)
This article provides an overview of Medifast, Inc. (NYSE: MED) stock, including its current price, historical performance, and analyst forecasts. It details financial actuals and estimates, discusses earnings reports, revenue, net income, market capitalization, volatility, and e
- Tone
- Negative 28/100
- Event
- Earnings
- Published
- 26 Jun 2026 15:39
- Source
- TradingView
Price to sales forward of Medifast, Inc. – BIVA:MED
This article provides access to the "Price to sales forward" financial data for Medifast, Inc. (MED) on the BIVA exchange through TradingView. It highlights the availability of financial metrics, news, community insights, and forecasts for the company. The content primarily acts
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 11:11
- Source
- TradingView
MED Forecast — Price Target — Prediction for 2027
This article provides a forecast for Medifast, Inc. (MED) stock, including a price target of 210.34 MXN based on one analyst's opinion. It details the company's financial performance, such as recent earnings and revenue, and offers various stock metrics like market capitalization
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Jun 2026 21:11
- Source
- TradingView
Medifast Inc (MED) Financial Health: Profitability & Balance Sheet Analysis
Medifast Inc (MED) currently holds a financial score of 7.16, placing it 51st out of 94 companies in the Food & Tobacco industry, indicating robust financial health despite average operating efficiency. The company reported a significant year-over-year decrease in its latest quar
- Tone
- Negative 19/100
- Event
- Market update
- Published
- 25 Jun 2026 00:11
- Source
- TradingKey
Medifast (MED) Loses 18.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Market source
Why the Essential 1 Month Kit from Medifast quietly fits busy routines
The article highlights Medifast's Essential 1 Month Kit, designed to integrate seamlessly into busy routines by offering a structured, portion-controlled weight management plan. It emphasizes the convenience and predictability of the kit, which includes pre-measured meal replacem
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Jun 2026 02:41
- Source
- AD HOC NEWS
Medifast Stock - Analyst expectations and business outlook
Medifast (MED) is under investor scrutiny as analysts reassess its performance against a changing weight-management market, especially with the rise of GLP-1 drugs. The company is transitioning from a coach-centric weight-loss model to a broader health and wellness strategy, a mo
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 18 Jun 2026 18:10
- Source
- AD HOC NEWS
Medifast Inc (MED) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Medifast Inc (MED), highlighting its major institutional shareholders and a breakdown of shareholder types. It provides data on institutional shareholding trends over several quarters and lists recent shareholder activity by key f
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 09:10
- Source
- TradingKey
Medifast Inc (MED) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
The article provides a revenue breakdown for Medifast Inc (MED), noting that relevant data for FY2025, FY2025Q4, FY2025Q2, FY2025Q1, and FY2024 by business segment has not yet been disclosed by the company. It indicates that the United States contributed $385.79 million to Medifa
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jun 2026 22:09
- Source
- TradingKey
Medifast Inc (MED) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Medifast Inc (MED), highlighting its current risk score and ranking within the Food & Tobacco industry. Key metrics such as beta value, VaR (Value at Risk), maximum drawdown, volatility, and liquidity are detailed. The report also notes
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 16 Jun 2026 20:41
- Source
- TradingKey
Medifast Inc (MED) Institutional Confidence
Medifast Inc's institutional confidence score is 7.00, placing it 24th out of 95 in the Food & Tobacco industry. The institutional shareholding proportion decreased by 2.48% quarter-over-quarter to 83.21%. James Simons is the largest institutional shareholder, holding 7.55% of sh
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 20:41
- Source
- TradingKey
Medifast Inc (MED) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Medifast Inc (MED), highlighting its stock price momentum, support and resistance levels, and insights from various technical indicators and moving averages. While the stock's current price momentum score is 5.30, trading between resi
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 16 Jun 2026 09:09
- Source
- TradingKey